Closed-Loop Vagus Nerve Stimulation (CLV) for Recovery of Gait After Spinal Cord Injury (SCI)

NCT07689227 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-07-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety, feasibility, and preliminary effectiveness of the ReWire system, which delivers vagus nerve stimulation (VNS) paired with lower limb rehabilitation to improve gait in individuals with mobility impairments resulting from chronic, incomplete spinal cord injury (SCI).

Conditions

  • Spinal Cord Injury (SCI)
  • Gait
  • Reduced Physical Activity
  • Lower Limb Functions
  • Walking Impairment
  • Mobility Impairment
  • Functional Mobility

Interventions

DEVICE

CLV

The participants in this group will be implanted with the ReWire system and receive CLV in the double-blind phase

DEVICE

Sham

The participants in this group will be implanted with the ReWire system and receive Sham in the double-blind phase

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH
  • The University of Texas at Dallas

    lead OTHER

Principal Investigators

  • Jane Wigginton, MD · The University of Texas at Dallas

  • Seth Hays, PhD · The University of Texas at Dallas

  • Robert Rennaker, PhD · The University of Texas at Dallas

  • Rita Hamilton, DO · Baylor University Medical Center (BUMC)

  • Chad Swank, PhD · Spaulding Rehabilitation Hospital, Mass General Brigham

  • Michael Foreman, MD · Urgent Surgery Associates, PA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2028-12-31
Completion
2028-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07689227 on ClinicalTrials.gov